William Harvey Research Institute, London
The William Harvey Research Institute is a London-based academic pharmacological research centre within Queen Mary University of London, conducting cardiovascular, endocrine, and inflammation research across seven specialised centres and three clinical facilities. It is funded by research grants, university allocation, and NHS partnership rather than commercial revenue.
- Company typePrivate
- Founded1986
- HeadquartersLondon, United Kingdom
- Headcount1,001–5,000
- GTM typeB2B
- OfferingServices
What William Harvey Research Institute, London does
The William Harvey Research Institute (WHRI) is a pharmacological research centre operating within the Faculty of Medicine and Dentistry at Queen Mary University of London, headquartered at Charterhouse Square, London. Founded in 1986, the institute conducts world-leading research across cardiovascular, endocrine, and inflammation science, organised into seven specialised research centres (Advanced Cardiovascular Imaging, Biochemical Pharmacology, Cardiovascular Medicine and Devices, Clinical Pharmacology and Precision Medicine, Endocrinology, Experimental Medicine and Rheumatology, Microvascular Research, and Translational Medicine and Therapeutics) and three clinical facilities (the William Harvey Clinical Research Centre, the William Harvey Heart Centre, and the Barts Cardiovascular Clinical Trials Unit). Its core activity spans basic science, translational research, clinical trials, and the education of undergraduate and postgraduate students.
WHRI does not operate a commercial business model: there is no disclosed pricing, no commercial distribution, and no commercial customer base. Funding derives from competitive research grants (most recently European Research Council funding awarded in 2026 to Professor Michelangelo Campanella for safer drug discovery), institutional allocation from Queen Mary University of London, and clinical-academic integration with Barts Health NHS Trust — the latter enabling direct bench-to-bedside translation through hospital-based activity at Barts Hospital and the Royal London Hospital. Its primary 'customers' in operational terms are postgraduate and undergraduate students, NHS patients participating in clinical research, and the broader academic and clinical research community.
The institute's value proposition rests on the structural integration of basic science, clinical pharmacology, and NHS-delivered patient care under a single institutional umbrella — a configuration that few standalone research organisations can replicate. Senior leadership is anchored by named principal investigators including Professor Sir Mark Caulfield (Vice President for Health, Professor of Clinical Pharmacology), Professor Lou Metherell (Endocrine Genetics), and Professor Michelangelo Campanella (ERC-funded principal investigator in drug safety).
William Harvey Research Institute, London firmographics
Firmographics- Name
- William Harvey Research Institute, London
- Legal name
- William Harvey Research Institute
- Website
- https://whri.qmul.ac.uk
- Company type
- Private
- Founded year
- 1986
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- The William Harvey Research Institute is a London-based academic pharmacological research centre within Queen Mary University of London, conducting cardiovascular, endocrine, and inflammation research across seven specialised centres and three clinical facilities. It is funded by research grants, university allocation, and NHS partnership rather than commercial revenue.
- Ownership category
- akta.pro rank
William Harvey Research Institute, London industry classification
Industry- Product category
- Academic & Medical Research
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical Laboratories (621511)
- SIC
- Services-Commercial Physical & Biological Research (8731), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)
- akta.pro secondary industry
- Health & Biomedical Research Universities (Academic Medical Center–Affiliated) (EDAHABAC)
Keywords
Where William Harvey Research Institute, London is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices3 records
Markets served
William Harvey Research Institute, London business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure
Marketing channels4 records
William Harvey Research Institute, London product offering
Product offeringCore offering
The William Harvey Research Institute is a pharmacological research centre within the Faculty of Medicine and Dentistry at Queen Mary University of London that conducts world-leading multidisciplinary research in cardiovascular, endocrine and inflammation science. It delivers undergraduate and postgraduate educational programmes, operates clinical research and cardiovascular care facilities in partnership with Barts Health NHS Trust, and houses specialised research centres spanning cardiovascular imaging, biochemical pharmacology, precision medicine and translational therapeutics.
Product overview
The William Harvey Research Institute offers a unified portfolio of educational programs and research/clinical services. Its educational offerings include undergraduate, postgraduate taught, and postgraduate research programs in cardiovascular, endocrine, and inflammation science. Its clinical infrastructure comprises three dedicated facilities: the William Harvey Clinical Research Centre (CRC), the William Harvey Heart Centre, and the Barts Cardiovascular Clinical Trials Unit (CVCTU). The Institute also houses seven specialized research centres covering cardiovascular imaging, biochemical pharmacology, cardiovascular medicine and devices, clinical pharmacology and precision medicine, endocrinology, experimental medicine and rheumatology, microvascular research, and translational medicine and therapeutics. Together, these form a comprehensive ecosystem bridging research, education, and clinical translation.
Differentiator
Problem solved
Functional benefit
Products and services
- Undergraduate Study Programs Undergraduate degree programmes at the William Harvey Research Institute delivered by research and clinical academic experts in cardiovascular, endocrine and inflammation science.
- Postgraduate Taught Programs Postgraduate taught (master's level) programmes delivered by WHRI researchers and clinical academics at Queen Mary University of London.
- Postgraduate Research Programs Research degree programmes (PhD) at WHRI for advanced study in cardiovascular, endocrine and inflammation research under the supervision of institute faculty.
- William Harvey Clinical Research Centre (CRC) Clinical research facility conducting translational research in partnership with Barts Health NHS Trust at Barts Hospital and Royal London Hospital.
- William Harvey Heart Centre Specialised clinical centre providing cardiovascular care and treatment within the Barts Health NHS Trust partnership.
- Barts Cardiovascular Clinical Trials Unit (CVCTU) Clinical trials unit conducting cardiovascular medicine trials and research studies in collaboration with Barts Health NHS Trust.
Quantifiable outcome
- 40 years of continuous research excellence in cardiovascular, endocrine and inflammation science
- +1 more outcomes
Companies that use William Harvey Research Institute, London
Customer profileSegments4 records
Ideal customer profiles3 records
William Harvey Research Institute, London technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
William Harvey Research Institute, London partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Barts Health NHS TrustcoreBarts Health NHS Trust is the key NHS partner of WHRI. Clinical academic activity and translational research take place at both Barts Hospital and the Royal London Hospital. This partnership enables the translation of laboratory research into clinical applications and provides the foundation for the William Harvey Clinical Research Centre and William Harvey Heart Centre.
- Queen Mary University of LondoncoreWHRI is an integral part of Queen Mary University's Faculty of Medicine and Dentistry. The institute operates within the university's infrastructure and governance framework, providing research and educational services to the university community.
Scale indicators2 records
Recent moves5 records
Expansion highlights5 records
William Harvey Research Institute, London competitors and assessment
Company assessmentMarket position
Strengths4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
William Harvey Research Institute, London social profiles
Digital presenceWilliam Harvey Research Institute, London compliance and trust
Trust signalCompliance1 record
William Harvey Research Institute, London financial estimates
Financial estimateRevenue estimate
Valuation estimate
William Harvey Research Institute, London leadership team
Management profileNumber of profiles
Profiles3 records
William Harvey Research Institute, London subsidiaries and ownership
Company hierarchySubsidiaries11 records
William Harvey Research Institute, London funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
William Harvey Research Institute, London M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about William Harvey Research Institute, London
What does William Harvey Research Institute, London do?
The William Harvey Research Institute is a pharmacological research centre within the Faculty of Medicine and Dentistry at Queen Mary University of London that conducts world-leading multidisciplinary research in cardiovascular, endocrine and inflammation science. It delivers undergraduate and postgraduate educational programmes, operates clinical research and cardiovascular care facilities in partnership with Barts Health NHS Trust, and houses specialised research centres spanning cardiovascular imaging, biochemical pharmacology, precision medicine and translational therapeutics.
Is William Harvey Research Institute, London a public or private company?
William Harvey Research Institute, London is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was William Harvey Research Institute, London founded?
William Harvey Research Institute, London was founded in 1986. It employs 1,001 to 5,000 people.
Where is William Harvey Research Institute, London based?
William Harvey Research Institute, London is headquartered in London, United Kingdom, in the Europe region.
Does William Harvey Research Institute, London have an API?
No public API is recorded for William Harvey Research Institute, London.
What industry is William Harvey Research Institute, London in?
William Harvey Research Institute, London's product category is Academic & Medical Research. Its primary akta.pro industry code is EDAHAGAI, Biomedical Sciences & Medical Research Institutes (University-Based), with a secondary code of EDAHABAC, Health & Biomedical Research Universities (Academic Medical Center–Affiliated). Its NAICS code is 541714 and its SIC code is 8731.